Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2002
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income
Operating Margin
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-1.2M
Net Margin
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 4 of 4 Older →